UPDF AI

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

L. Borradori,N. van Beek,53 Authors,P. Joly

2022 · DOI: 10.1111/jdv.18220
Journal of the European Academy of Dermatology and Venereology · 219 Citations

TLDR

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes and has high morbidity and severely impacts the quality of life.

Abstract

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullous lesions. A subset of patients only develops excoriations, prurigo‐like lesions, and eczematous and/or urticarial erythematous lesions. The disease, which is significantly associated with neurological disorders, has high morbidity and severely impacts the quality of life.